High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis

Highlights SRSF9 is a potential independent risk factor for HCC. High methylation status of cg06116271 predicted a better prognosis in HCC. SRSF9 knockdown inhibited the Wnt signaling pathway and cell cycle pathway. SRSF9 may serve as a potential therapeutic target for HCC.

Bibliographic Details
Main Authors: Guoshun Zhang, Bin Liu, Hua Shang, Guikai Wu, Diyang Wu, Liuqing Wang, Shengnan Li, Zhiyuan Wang, Suying Wang, Juxiang Yuan
Format: Article
Language:English
Published: BMC 2022-08-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-022-01316-7
_version_ 1818498025530589184
author Guoshun Zhang
Bin Liu
Hua Shang
Guikai Wu
Diyang Wu
Liuqing Wang
Shengnan Li
Zhiyuan Wang
Suying Wang
Juxiang Yuan
author_facet Guoshun Zhang
Bin Liu
Hua Shang
Guikai Wu
Diyang Wu
Liuqing Wang
Shengnan Li
Zhiyuan Wang
Suying Wang
Juxiang Yuan
author_sort Guoshun Zhang
collection DOAJ
description Highlights SRSF9 is a potential independent risk factor for HCC. High methylation status of cg06116271 predicted a better prognosis in HCC. SRSF9 knockdown inhibited the Wnt signaling pathway and cell cycle pathway. SRSF9 may serve as a potential therapeutic target for HCC.
first_indexed 2024-12-10T18:52:41Z
format Article
id doaj.art-82d0ce5fcc634b2b8a87205884584b47
institution Directory Open Access Journal
issn 1755-8794
language English
last_indexed 2024-12-10T18:52:41Z
publishDate 2022-08-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj.art-82d0ce5fcc634b2b8a87205884584b472022-12-22T01:37:16ZengBMCBMC Medical Genomics1755-87942022-08-0115111110.1186/s12920-022-01316-7High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosisGuoshun Zhang0Bin Liu1Hua Shang2Guikai Wu3Diyang Wu4Liuqing Wang5Shengnan Li6Zhiyuan Wang7Suying Wang8Juxiang Yuan9School of Public Health, North China University of Science and TechnologyDepartment of Gastroenterology, Chaisang District People’s HospitalBlood Purification Department of Tangshan Infectious Disease HospitalDepartment of Gastroenterology, Tangshan Workers’ HospitalDepartment of Gastroenterology, Tangshan Workers’ HospitalDepartment of Gastroenterology, Hongci HospitalDepartment of Gastroenterology, Affiliated Hospital of North China University of TechnologyDepartment of Gastroenterology, Affiliated Hospital of North China University of TechnologyDepartment of Gastroenterology, Affiliated Hospital of North China University of TechnologySchool of Public Health, North China University of Science and TechnologyHighlights SRSF9 is a potential independent risk factor for HCC. High methylation status of cg06116271 predicted a better prognosis in HCC. SRSF9 knockdown inhibited the Wnt signaling pathway and cell cycle pathway. SRSF9 may serve as a potential therapeutic target for HCC.https://doi.org/10.1186/s12920-022-01316-7SRSF9Hepatocellular carcinomaBiomarkerscg06116271Prognosis
spellingShingle Guoshun Zhang
Bin Liu
Hua Shang
Guikai Wu
Diyang Wu
Liuqing Wang
Shengnan Li
Zhiyuan Wang
Suying Wang
Juxiang Yuan
High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
BMC Medical Genomics
SRSF9
Hepatocellular carcinoma
Biomarkers
cg06116271
Prognosis
title High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
title_full High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
title_fullStr High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
title_full_unstemmed High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
title_short High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
title_sort high expression of serine and arginine rich splicing factor 9 srsf9 is associated with hepatocellular carcinoma progression and a poor prognosis
topic SRSF9
Hepatocellular carcinoma
Biomarkers
cg06116271
Prognosis
url https://doi.org/10.1186/s12920-022-01316-7
work_keys_str_mv AT guoshunzhang highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT binliu highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT huashang highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT guikaiwu highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT diyangwu highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT liuqingwang highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT shengnanli highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT zhiyuanwang highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT suyingwang highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis
AT juxiangyuan highexpressionofserineandargininerichsplicingfactor9srsf9isassociatedwithhepatocellularcarcinomaprogressionandapoorprognosis